Table 3.
MAC (+) | MAC (−) | P value | |||
---|---|---|---|---|---|
n | Hs-CRP (mg/dL) | n | Hs-CRP (mg/dL) | ||
All patients | 100 | 2.02 ± 0.35 | 100 | 1.43 ± 0.47 | <0.001 |
Females | 64 | 2.05 ± 0.35 | 45 | 1.64 ± 0.39 | <0.001 |
Males | 36 | 1.97 ± 0.34 | 55 | 1.26 ± 0.47 | <0.001 |
CAD (+) | 37 | 2.10 ± 0.33 | 18 | 1.77 ± 0.30 | 0.001 |
CAD (−) | 63 | 1.97 ± 0.35 | 82 | 1.36 ± 0.47 | <0.001 |
HT (+) | 42 | 1.97 ± 0.39 | 28 | 1.90 ± 0.34 | 0.47 |
HT (−) | 58 | 2.06 ± 0.32 | 72 | 1.25 ± 0.39 | <0.001 |
CAD (+): patients with coronary artery disease.
CAD (−): patients without coronary artery disease, Hs-CRP: high-sensitivity C-reactive protein in mg/dL.
HT (+): patients with hypertension.
HT (−): patients without hypertension.
MAC (+): patients with mitral annular calcification.
MAC (−): patients without mitral annular calcification.